NRIX Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Nurix Therapeutics Inc

Watchlist Manager

Watchlist

Price: 22.9 USD 1.96% Market Closed

Market Cap: $2.4B

	Nurix Therapeutics Inc NASDAQ:NRIX	US
	ActiveOps PLC F:95D	UK

Profitability Summary

Nurix Therapeutics Inc's profitability score is 5/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-439%

Negative 3Y Average Operating Margin

-307%

Declining Operating Margin

-271% > -439%

Negative Net Margin

-411%

Negative 3Y Average Net Margin

-283%

Declining Net Margin

-258% > -411%

Negative Free Cash Flow Margin

-379%

Negative 3Y Average Free Cash Flow Margin

-250%

Declining Free Cash Flow Margin

-263% > -379%

Negative ROE

-61%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-313%

Declining ROIC

-212% > -445%

View All

Hide

Collapse

5 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.